Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

46.10p
   
  • Change Today:
      0.25p
  • 52 Week High: 49.55p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 324,847
  • Market Cap: £249.20m
  • RiskGrade: 119
  • Beta: 0.92

Broker List

Order by
Date Broker name New Price Old price target New price target Broker change
31-Jan-24 RBC Capital Markets Outperform 37.55p 65.00p 60.00p Reiteration
26-Sep-23 Peel Hunt Limited Hold 48.40p - 53.00p Reiteration
25-May-23 Berenberg Bank Buy 62.30p - 105.00p Reiteration
25-May-23 Numis Buy 62.30p - 105.00p Reiteration
13-Sep-17 Investec Securities Buy 52.75p - 59.00p New Coverage
13-Sep-17 N 1 Singer Not Rated 52.75p - - Reiteration
18-Jul-17 Numis Securities Buy 52.50p - 60.00p Reiteration
09-May-17 FinnCap Buy 49.00p - 65.00p Reiteration
13-Jul-15 Canaccord Genuity Hold 45.00p 40.00p 40.00p Reiteration

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 46.10p
Change Today 0.25p
% Change 0.55 %
52 Week High 49.55p
52 Week Low 29.35p
Volume 324,847
Shares Issued 540.57m
Market Cap £249.20m
Beta 0.92
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
14.62% below the market average14.62% below the market average14.62% below the market average14.62% below the market average14.62% below the market average
64.00% above the sector average64.00% above the sector average64.00% above the sector average64.00% above the sector average64.00% above the sector average
Price Trend
50.88% above the market average50.88% above the market average50.88% above the market average50.88% above the market average50.88% above the market average
79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average79.59% above the sector average
Income Not Available
Growth
38.06% below the market average38.06% below the market average38.06% below the market average38.06% below the market average38.06% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 20-Dec-2024

Time Volume / Share Price
16:29 76 @ 46.45p
16:28 207 @ 46.10p
16:22 4 @ 46.00p
16:15 64 @ 46.40p
16:13 140 @ 46.15p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page